Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Eli Lilly Predicts Medicare Coverage Of Zepbound Will Draw Current DTC Customers
Feb 05 2026
•
By
Cathy Kelly
Medicare coverage was a long-sought opportunity for obesity drugs.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from Government Payers